Doctor profile · Federal record
Dr. Amer Zeidan
Hematology & Oncology Physician (CMS: Medical Oncology) · Medical Oncology Physician · Hospitalist Physician · Hematology (Internal Medicine) Physician · New Haven, CT
- NPI 1083819528
- Accepts Medicare
- MIPS 71.7 / 100 · 2023
- 25 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
333 Cedar St
New Haven, CT 065103206
(203) 737-7103 - Mailing address
-
1425 Portland Ave, Box 287
Rochester, NY 146213001
Credentials & registration
- NPI registered
- June 2007 — 19 yrs on file
- Profile last updated
- September 18, 2014
- Year of graduation
- 2001 — 25 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (2)
- Connecticut #053058 · New York #002864-1
- Medicaid
- NY #02892919
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1083819528. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
103
Distinct HCPCS
2
Medicare allowed
$12,437
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 65 | 26 | $103 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 38 | 22 | $151 |
In context: peer comparison
Among 11 peers in New Haven Hematology & Oncology Physician, average services per provider: 368. This provider delivers 0.3× the peer median.Open Payments
Industry payments received
All-time total
$110,326
Transactions
41
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Taiho Oncology, INC. | 5 | $21,915.00 | |
| BioCryst Pharmaceuticals, INC. | 1 | $21,000.00 | |
| Chiesi USA, INC. | 8 | $17,400.00 | |
| Agios Pharmaceuticals, INC. | 6 | $13,338.20 | |
| Abbvie INC. | 4 | $7,723.10 | |
| Rigel Pharmaceuticals, INC. | 1 | $5,480.00 | |
| Karyopharm Therapeutics INC. | 1 | $4,890.00 | |
| Daiichi Sankyo INC. | 4 | $4,082.62 | |
| Kyowa Kirin, INC. | 2 | $3,925.00 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $3,092.86 | |
| Celgene Corporation | 1 | $3,000.00 | |
| Astellas Pharma Global Development | 1 | $2,400.00 | |
| BeiGene USA, INC. | 2 | $2,062.10 | |
| Kyowa Kirin Co., LTD | 1 | $17.16 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
15
Patients
0
Total drug cost
$464,274
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Idhifa (Enasidenib Mesylate) | Brand | 15 | 0 | $464,274 |
Frequently asked questions
What is Dr. Amer Zeidan's medical specialty?
Dr. Amer Zeidan practices Hematology & Oncology Physician in New Haven, CT.
Where does Dr. Amer Zeidan practice?
Dr. Amer Zeidan practices at 333 Cedar St, New Haven, CT 065103206. Office phone: 2037377103.
What is Dr. Amer Zeidan's NPI?
Dr. Amer Zeidan's National Provider Identifier (NPI) is 1083819528, issued by NPPES.
Does Dr. Amer Zeidan accept Medicare assignment?
Yes. Dr. Amer Zeidan accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Amer Zeidan commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99215). Source: CMS Medicare Physician & Other Practitioners file.